Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.06 - $1.67 $157 - $248
149 Added 1.06%
14,166 $16,000
Q4 2023

Feb 13, 2024

SELL
$1.26 - $1.79 $225 - $320
-179 Reduced 1.26%
14,017 $23,000
Q3 2023

Nov 13, 2023

SELL
$1.61 - $2.54 $1,344 - $2,120
-835 Reduced 5.56%
14,196 $25,000
Q2 2023

Aug 04, 2023

BUY
$1.14 - $1.95 $6,207 - $10,617
5,445 Added 56.8%
15,031 $27,000
Q1 2023

May 12, 2023

SELL
$1.2 - $2.19 $276 - $503
-230 Reduced 2.34%
9,586 $12,000
Q4 2022

Feb 10, 2023

BUY
$1.63 - $3.52 $570 - $1,232
350 Added 3.7%
9,816 $16,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $18 - $97
26 Added 0.28%
9,466 $30,000
Q2 2022

Aug 12, 2022

BUY
$2.2 - $4.2 $20,768 - $39,648
9,440 New
9,440 $22,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.